Hepatitis C, Chronic

Showing 26 - 50 of 338

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic Trial in Melbourne (EC clinic support - whole of practice interventions

Recruiting
  • Hepatitis C
  • +2 more
  • EC clinic support - whole of practice interventions delivery through nurse-led model
  • Melbourne, Victoria, Australia
    Burnet Institute
Aug 22, 2021

Hepatitis C, Chronic, HIV Infection Trial in Hai Phong, Ho Chi Minh City (Raltegravir, Efavirenz)

Completed
  • Hepatitis C, Chronic
  • HIV Infection
  • Hai Phong, Vietnam
  • +1 more
Jul 21, 2021

Hepatitis C, Chronic Trial (ABT-450/r, ABT-267, Ribavirin (RBV))

Completed
  • Hepatitis C, Chronic
  • (no location specified)
Jul 28, 2021

Hepatitis C, Chronic, Non-Alcoholic Fatty Liver Disease Trial in Aurora (Cholate-24-13C (IND 65121) & Cholate-2,2,4,4-d4 (IND

Completed
  • Hepatitis C, Chronic
  • Non-Alcoholic Fatty Liver Disease
  • Cholate-24-13C (IND 65121) & Cholate-2,2,4,4-d4 (IND 65123)
  • Aurora, Colorado
    University of Colorado Hospital
Jun 24, 2021

Hepatitis C, Chronic Trial (HCV RNA (PCR), HCV Antibody test (Point of care), AST/ALT and platelets measurement)

Not yet recruiting
  • Hepatitis C, Chronic
  • HCV RNA (PCR)
  • +2 more
  • (no location specified)
Jun 29, 2021

Cohort Study on People Who Inject Drugs in Senegal

Active, not recruiting
  • Drug Addiction
  • +8 more
    • Dakar, Senegal
      CEPIAD
    Jun 7, 2021

    Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

    Completed
    • Hepatitis C, Chronic
    • Bilaspur, Chhattisgarh, India
      YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
    Apr 26, 2021

    Hepatitis C, Chronic, Opioid-Related Disorders Trial in Germany

    Completed
    • Hepatitis C, Chronic
    • Opioid-Related Disorders
      • Munich, Bavaria, Germany
      • +17 more
      Apr 27, 2021

      Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)

      Completed
      • Hepatitis C, Chronic
      • Chennai, Tamil Nadu, India
        YR Gaitonde Centre for AIDS Research and Education
      Mar 22, 2021

      Pathways for Efficacy, Cost Effectiveness and Cure in NHS

      Completed
      • Hepatitis C, Chronic
        • Dundee, United Kingdom
          NHS Tayside
        Mar 5, 2021

        Hepatitis C, Chronic Trial (Boceprevir, Peginterferon alfa-2b (PEG2b), Ribavirin (RBV))

        Completed
        • Hepatitis C, Chronic
        • (no location specified)
        Jan 15, 2021

        Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,

        Completed
        • Hepatitis C, Chronic
        • ombitasvir, paritaprevir/r, dasabuvir + ribavirin
        • ombitasvir, paritaprevir/r, dasabuvir
        • Irvine, California
        • +3 more
        Jan 21, 2021

        Hepatitis C, Chronic Trial in Pittsburgh

        Completed
        • Hepatitis C, Chronic
          • Pittsburgh, Pennsylvania
            UPMC Shadyside Family Health Center
          Jan 14, 2021

          Hepatitis C, Chronic Trial in Worldwide (Abbott RealTime HCV assay from DBS, HCV for use on the cobas® 6800/8800 Systems from

          Completed
          • Hepatitis C, Chronic
          • Abbott RealTime HCV assay from DBS
          • +3 more
          • Victoria Park, Fitzroy, Australia
          • +4 more
          Dec 16, 2020

          Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

          Completed
          • Hepatitis C, Chronic
          • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
          • Riyadh, Saudi Arabia
            King Fahad Medical City
          Nov 18, 2020

          Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)

          Completed
          • Hepatitis C, Chronic
          • Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
          • Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
          • (no location specified)
          Aug 24, 2020

          MDD, Hepatitis C, Chronic Trial in Spain (Escitalopram, Placebo)

          Completed
          • Major Depressive Disorder
          • Hepatitis C, Chronic
          • Alcorcon, Spain
          • +14 more
          Aug 5, 2020

          Hepatitis C, Chronic Trial in Glasgow (Follow up phone call, Incentive)

          Unknown status
          • Hepatitis C, Chronic
          • Follow up phone call
          • Incentive
          • Glasgow, United Kingdom
            Glasgow Royal Infirmary
          Jul 21, 2020

          Hepatitis C, Chronic Trial in Georgia (HCV viremia testing approaches)

          Completed
          • Hepatitis C, Chronic
          • HCV viremia testing approaches
          • Batumi, Georgia
          • +7 more
          Jul 21, 2020

          Voices From Black Community: Hepatitis C Research Participation

          Completed
          • Hepatitis C, Chronic
            • Chapel Hill, North Carolina
              University of North Carolina at Chapel Hill
            Jun 29, 2020

            Hepatitis C, Chronic, Heart Failure, Pulmonary Disease, Chronic Obstructive Trial in United States (Sofosbuvir/ledipasvir fixed

            Completed
            • Hepatitis C, Chronic
            • +3 more
            • Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC)
            • Detroit, Michigan
            • +3 more
            Apr 8, 2020

            Observational Study in HCV Chronic Infection

            Completed
            • Hepatitis C, Chronic
              • Rome, Italy
                Istituto Superiore di Sanità
              Apr 14, 2020

              Project BEST: Buprenorphine Entry Into Substance Abuse Treatment

              Completed
              • Opioid-related Disorders
              • +3 more
              • New Haven, Connecticut
                Yale University
              Apr 1, 2020

              Chronic Hepatitis C, Hepatitis C, Hepatitis C, Chronic Trial in Antwerp, Chisinau (AT-527, Placebo Comparator)

              Completed
              • Chronic Hepatitis C
              • +2 more
              • Antwerp, Belgium
              • +1 more
              Feb 14, 2020